<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yu Y</submitter><funding>Ninth People's Hospital, Shanghai Jiao-Tong University School of Medicine</funding><funding>Clinical Research Program of 9th People's Hospital affiliated to Shanghai Jiao-Tong University School of Medicine</funding><pagination>e71606</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12906978</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Hepatic involvement is a life-threatening complication in natural killer/T-cell lymphoma with hemophagocytic lymphohistiocytosis (NK/T-HLH). Nevertheless, the prognostic implications of hepatic dysfunction and its underlying related factors are not fully elucidated.&lt;h4>Methods&lt;/h4>We retrospectively analyzed the clinical and laboratory data of 53 NK/T patients, comprising 35 cases without HLH and 18 with HLH. All NK/T-HLH patients exhibited hepatic injury, characterized by significantly elevated hepatic enzyme levels and bilirubin compared to those without HLH (all p &lt; 0.001). Glutamyltransferase (GGT), aspartate aminotransferase (AST), and direct bilirubin (DBIL) individually predicted mortality with AUC > 0.8 in NKTCL patients, while their composite GSD index enhanced </pubmed_abstract><journal>Cancer medicine</journal><pubmed_title>IFN-γ Driven Hepatic Injury Exacerbates Mortality in NK/T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.</pubmed_title><pmcid>PMC12906978</pmcid><funding_grant_id>JYLJ202213</funding_grant_id><funding_grant_id>YJXKB202005</funding_grant_id><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Lu W</pubmed_authors><pubmed_authors>Shi J</pubmed_authors><pubmed_authors>Hang H</pubmed_authors><pubmed_authors>Pang Y</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors><pubmed_authors>Yu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>IFN-γ Driven Hepatic Injury Exacerbates Mortality in NK/T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.</name><description>&lt;h4>Background&lt;/h4>Hepatic involvement is a life-threatening complication in natural killer/T-cell lymphoma with hemophagocytic lymphohistiocytosis (NK/T-HLH). Nevertheless, the prognostic implications of hepatic dysfunction and its underlying related factors are not fully elucidated.&lt;h4>Methods&lt;/h4>We retrospectively analyzed the clinical and laboratory data of 53 NK/T patients, comprising 35 cases without HLH and 18 with HLH. All NK/T-HLH patients exhibited hepatic injury, characterized by significantly elevated hepatic enzyme levels and bilirubin compared to those without HLH (all p &lt; 0.001). Glutamyltransferase (GGT), aspartate aminotransferase (AST), and direct bilirubin (DBIL) individually predicted mortality with AUC > 0.8 in NKTCL patients, while their composite GSD index enhanced </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-15T15:43:18.457Z</modification><creation>2026-07-06T03:12:29.792Z</creation></dates><accession>S-EPMC12906978</accession><cross_references><pubmed>41692467</pubmed><doi>10.1002/cam4.71606</doi></cross_references></HashMap>